Arbutus Biopharma (ABUS) Capital Expenditures Growth (3y) (2016 - 2024)
Arbutus Biopharma (ABUS) Capital Expenditures Growth (3y) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -12.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 14.03% |
| Jun 30, 2024 | -88.35% |
| Mar 31, 2024 | -1.37% |
| Sep 30, 2023 | 42.75% |
| Jun 30, 2023 | 135.22% |
| Dec 31, 2022 | 28.60% |
| Sep 30, 2022 | -29.07% |
| Jun 30, 2022 | -4.05% |
| Mar 31, 2022 | 34.25% |
| Dec 31, 2021 | -36.54% |
| Sep 30, 2021 | -56.14% |
| Jun 30, 2021 | 14.14% |
| Mar 31, 2021 | -26.37% |
| Dec 31, 2020 | -6.84% |
| Sep 30, 2020 | -72.66% |
| Jun 30, 2020 | -72.35% |
| Dec 31, 2019 | -71.06% |
| Sep 30, 2019 | -1.40% |
| Jun 30, 2019 | -36.87% |
| Mar 31, 2019 | -51.75% |